At the interface: Crystal structures of phospholipases A2

Toxicon

Volumn 36, Issue 11, 1998, Pages 1623-1633

  Ward, R J ^a   De Azevedo Jr , W F ^a   Arni, R K ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTIC ACID; CALCIUM ION; LYSINE; PHOSPHOLIPASE A2; SNAKE VENOM;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; BIOPHYSICS; CONFERENCE PAPER; CRYSTAL STRUCTURE; CYTOLYSIS; MEMBRANE DAMAGE; NONHUMAN; PRIORITY JOURNAL; SEQUENCE ANALYSIS; STRUCTURE ACTIVITY RELATION; X RAY CRYSTALLOGRAPHY;

AGKISTRODON; ANIMALS; BOTHROPS; CALCIUM; CROTALID VENOMS; CRYSTALLOGRAPHY, X-RAY; DIMERIZATION; MODELS, MOLECULAR; PHOSPHOLIPASES A; PROTEIN CONFORMATION; SEQUENCE ANALYSIS; TRIMERESURUS;

EID: 0031792001     PISSN: 00410101     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-0101(98)00155-X     Document Type: Conference Paper

References (62)

1. Arni R. K., Ward R. J., Gutiérrez J. M., Tulinsky A. Structure of a calcium-independent phospholipase-like myotoxic protein from Bothrops asper venom. Acta Cryst. D. 51:1995;311-317.
2. 2: A structural review. Toxicon. 34:1996;827-841.
3. 2-homologue from Bothrops moojeni venom. Prot. Pep. Lett. 4:1997;329-334.
4. 2-homologue from Bothrops pirajai venom. Toxicon (in press).
5. 2 homologue isolated from the venom of Cerrophidion (Bothrops) godmani. Arch. Biochem. Biophys. (submitted).
6. 2 from Vipera russelli snake venom by guanidination of lysine residues. Toxicon. 32:1994;749-752.
7. Bon C., Changeux J.-P., Jeng T. W., Fraenkel-Conrat H. Post-synaptic effects of crotoxin and its isolated subunits. Eur. J. Biochem. 99:1979;471-481.
8. 2 at 2.5 Å. Access to a shielded catalytic site. J. Biol. Chem. 260:1985;9742-9749.
9. Carson M. Ribbons 2.0. J. Appl. Cryst. 24:1991;958-961.
10. Chang C. C., Lee C. Y., Eaker D., Fohlman J. The presynaptic neuromuscular blocking action of taipoxin. A comparison with β-bungarotoxin and crotoxin. Toxicon. 15:1977;571-576.
11. Chang L.-S. Chemical modification of notexin from Notechis scutatus scutatus (Australian tiger snake) venom with pyridoxal-5′-phosphate. J. Prot. Chem. 15:1996;473-480.
12. 2. Thromb. Hemostasis. 45:1981;82-89.
13. 2. Toxicon. 19:1981;705-720.
14. 2. J. Biol. Chem. 269:1994;13057-13060.
15. 2 engineering. The structural and functional roles of aromaticity and hydrophobicity in the conserved phenylalanine-22 and phenylalanine-106 aromatic sandwich. Biochemistry. 31:1992;10576-10583.
16. 2, anticoagulant and myotoxic activities. Biochem. Biophys. Acta. 1070:1991;455-460.
17. 2 isolated from B. asper and B. godmani snake venoms: effects on enzymatic and pharmacological properties. Toxicon. 35:1997;241-252.
18. 2 from Hemachatus hemachatus snake venom II. Pharmacological properties in relationship to enzymatic activity. Biochem. Pharmacol. 29:1980;1565-1575.
19. 2 from elapid snake venoms. Toxic. Appl. Pharmac. 59:1981;375-382.
20. 2. Arch. Biochem. Biophys. 284:1991;352-359.
21. Gerrard J. M., Robinson P., Narvey M., McNicol A. Increased phosphatidic acid and decreased lysophosphatidic acid in response to thrombin is associated with inhibition of platelet aggregation. Biochem. Cell Biol. 71(9-10):1993;432-439.
22. Gutiérrez J. M., Arroyo O., Bolanos R. Mionecrosis, hemorragia y edema inducidos por el veneno de Bothrops asper en ratón blanco. Toxicon. 18:1980;603-610.
23. Gutierrez J. M., Lomonte B. Review article. Phospholipase A2 myotoxins from Bothrops snake venoms. Toxicon. 33:1995;1405-1424.
24. Harris, J. B. (1991) Phospholipases in snake venoms and their effects on nerve and muscle. In Snake Toxins, ed. A. L. Harvey, pp. 91-129. Pergamon Press, New York.
25. 2. Methods Enzymol. 197:1991;201-215.
26. 2 from the venom of the cottonmouth snake at 2.0-Å resolution. J. Biol. Chem. 265:1990;17649-17656.
27. Homsi-Brandenburgo M. I., Queiroz L. S., Santo-Neto H., Rodrigues-Simoni L., Giglio J. R. Fractionation of Bothrops jararacussu snake venom: partial chemical characterization and biological activity of Bothropstoxin. Toxicon. 26(7):1988;615-627.
28. 2 of Vipera russelli snake venom. Toxicon. 22:1984;359-365.
29. 2 and phospholipid bilayers. Biochem. Biophys. Acta. 688:1982;341-348.
30. 2 in intravesicle scooting mode, and heterofusion of anionic and zwitterionic vesicles. Biochem. Biophys. Acta. 860:1986;435-447.
31. Johnson E. K., Ownby C. L. Isolation of a myotoxin from the venom of Agkistrodon contortrix laticinctus (broad-banded copperhead) and pathogenesis of myonecrosis induced by it in mice. Toxicon. 31:1993;243-255.
32. 2 engineering. Structural and functional roles of the highly conserved active site residue aspartate-49. Biochemistry. 33:1994;14714-14722.
33. 2 homolog from the venom of Trimeresurus mucrosquamatus. Biochim. Biophys. Acta. 1077:1991;362-370.
34. 2 purified from porcine pancreas and snake venoms. Toxicon. 31(8):1993;949-956.
35. 2 from the venom of the snake Bothrops asper by monoclonal antibodies. Toxicon. 30:1992;239-245.
36. 2 from Bothrops asper snake venom. Identification of a heparin-binding and cytolytic toxin region by the use of synthetic peptides and molecular modelling. J. Biol. Chem. 269:1994;29867-29873.
37. 2. Biochem. Mol. Biol. Int. 42:1997;1171-1177.
38. 2 with lysine in place of aspartate 49. J. Biol. Chem. 259:1984;13839-13843.
39. Mebs, D. (1986) Myotoxic activity of phospholipases A2 isolated from cobra venoms: neutralization by polyvalent antivenoms. Toxicon 24, 1001-1008.
40. Mollier P., Chwetzoff S., Bouet F., Harvey A. L., Menez A. Tryptophan 110, a residue involved in the toxic activity but not in the catalytic activity of notexin. Eur. J. Biochem. 185:1989;2634-2640.
41. 2 isozymes. Proc. Natl. Acad. Sci. U.S.A. 89:1992;8557-8561.
42. Pedersen Z. P., de Arcuri B. F., Morero R. D., Rufini S. Phospholipase-like myotoxins induce rapid membrane leakage of non-hydrolyzable ether-lipid liposomes. Biochem. Biophys. Acta. 1190:1994;177-180.
43. Pedersen J. Z., Lomonte B., Massoud R., Gubensek F., Gutiérrez J. M., Rufini S. Autocatalytic acylation of phospholipase-like myotoxins. Biochemistry. 34:1995;4670-4675.
44. 2 and its zymogen with divalent metal ions. Biochemistry 13, 1439-1445.
45. 2 at the bilayer interface. Prot. Struct. Funct. Genet. 9:1991;229-239.
46. 2 from bovine pancreas and Crotalus atrox venom. J. Biol. Chem. 260:1985;11627-11636.
47. 2 by modification of carboxylate groups. Biochem. Pharmacol. 32:1983;3525-3530.
48. Rufini S., Cesaroni P., Desideri R. F., Gubensek F., Gutiérrez J. M., Luly P., Maassoud R., Morero R., Pedersen J. Z. Calcium ion independent membrane leakage induced by phospholipase-like myotoxins. Biochemistry. 31:1992;12424-12430.
49. Scott D. L., Otwinowski Z., Gelb M. H., Sigler P. B. Crystal structure of bee venom phospholipase A2 in a complex with a transition state analogue. Science. 250:1990;1563-1566.
50. 2. Science. 250:1990;1541-1546.
51. 2 from the venom of Agkistrodon piscivorus piscivorus. J. Biol. Chem. 267:1992;22645-22657.
52. 2 myotoxin from the venom of Agkistrodon contortrix laticinctus snake venom. Arch. Biochem. Biophys. 326:1996;21-30.
53. 2 myotoxins: a highly conserved class of proteins. Toxicon. 34:1996;1237-1242.
54. da Silva Giotto et al. (1997).
55. 2 homologue. Prot. Struct. Funct. Genet. 30, 442-454.
56. Takasaki C., Suzuki J., Tamiya N. Purification and properties of several phospholipases A2 from the venom of Australian King Brown snake (Pseudechis australis). Toxicon. 28:1990;319-327.
57. 2. Biochem. Biophys. Acta. 70:1963;538-553.
58. 2 and their importance for enzymatic activity. J. Cell. Biochem. 39:1989;379-390.
59. 2 on enzymatic activity and substrate binding properties. Biochemistry 21, 1345-1352.
60. Ward et al. (1997).
61. 2: clues towards identification of residues involved in a novel mechanism of membrane damage and in myotoxicity. Prot. Eng. 11, 285-294.
62. 2: A potent inhibitor of platelet aggregation. Thromb. Res. 70(6):1993;471-481.